Form 4: Sotera Health Director Karen Flynn Receives RSU Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Director Karen Flynn was granted 14,970 restricted stock units in Sotera Health Co as part of the company's 2020 Omnibus Incentive Plan.

Summary

  • Director Karen Flynn acquired 14,970 restricted stock units (RSUs) on May 22, 2026.
  • The grant was issued under the Sotera Health Company 2020 Omnibus Incentive Plan.
  • Each RSU represents a right to receive one share of common stock upon vesting.
  • The total beneficial ownership for the director following this transaction is 54,191 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • None identified; this is a standard equity compensation disclosure.

Risks

  • Vesting is subject to the director's continued service with the company.

Future Outlook

The RSUs will vest in full on the earlier of the first anniversary of the grant date or the date immediately prior to the next regular annual shareholders meeting, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

  • The use of RSU grants for director compensation is consistent with standard practices for mid-to-large cap healthcare and life sciences companies.
  • Vesting schedules tied to annual shareholder meetings are common among publicly traded firms to align director tenure with the annual election cycle.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity CompensationGrant of 14,970 RSUs to a non-employee director.05/22/2026Standard alignment of director incentives.

Stakeholder Impact

  • Minimal impact on shareholders; represents standard director compensation.

Next Steps

  • Vesting of the 14,970 RSUs on the earlier of May 22, 2027, or the date of the next annual shareholders meeting.

Key Dates

DateDescription
05/22/2026Date of RSU grant transaction.
05/27/2026Date of filing.

Keywords

Sotera Health, SHC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.